Cart
sales@molnova.com
Rbin-2
CAS No. 2032282-97-4
Rbin-2( —— )
Catalog No. M34391 CAS No. 2032282-97-4
Rbin-2 is a cell-permeable, potent, selective and reversible inhibitor of Midasin (Mdn1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 30 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 198 | In Stock |
|
| 50MG | 310 | In Stock |
|
| 100MG | 453 | In Stock |
|
| 200MG | 631 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRbin-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionRbin-2 is a cell-permeable, potent, selective and reversible inhibitor of Midasin (Mdn1).
-
DescriptionRbin-2 is a potent, reversible and selective inhibitor of Midasin (Mdn1), an enzyme belonging to the AAA+ (ATPases associated with diverse cellular activities) protein family. Rbin-2 inhibits eukaryotic ribosome biogenesis and is a powerfulprobe for the eukaryotic ribosome assembly.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPhosphatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2032282-97-4
-
Formula Weight335.22
-
Molecular FormulaC13H11BrN4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 8.33 mg/mL (24.85 mM; Ultrasonic (<60°C)
-
SMILESS(CC(C)=C)C=1N=C2C(C=3C(N2)=CC(Br)=CC3)=NN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kawashima SA, et al. Potent, Reversible, and Specific Chemical Inhibitors of Eukaryotic Ribosome Biogenesis. Cell. 2016 Oct 6;167(2):512-524.e14. ?
molnova catalog
related products
-
MB05032
MB05032 is a potent fructose-,-bisphosphatase inhibitor that inhibits gluconeogenesis and reduces d-lactate-triggered ETosis.
-
Desfesoterodine
5-hydroxymethyl tolterodine (PNU 200577) is a new muscarinic receptor antagonist with Kb of 0.84 nM.
-
SHP099
SHP099 free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.
